Stoke Therapeutics Market Sentiment

Stoke Therapeutics Inc

STOKNASDAQ

$26.13

0.672.63%

Dern. MÀJ: Oct 28, 7:23 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Résultats: Résultats Q3 2026 demain le jeu. oct. 29th après la fermeture du marché

Conférence téléphonique: Conférence téléphonique prévue demain à 4:30 PM

Cliquez pour voir la webdiffusion

Stoke Therapeutics Market Sentiment - Benzinga

Stoke Therapeutics Market Sentiment

Market sentiment signals for Stoke Therapeutics (STOK): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 19.2% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

15 analysts

Options Flow (P/C)

—

Avg Consensus PT

$41

+57.1%

Highest Price Target

$60

+129.1%

Guggenheim

Lowest Price Target

$24

-8.4%

Chardan Capital

Short Interest

19.2%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 21, 2026	JP Morgan	Jessica Fye—	+52.7%	$40	Reinstates	Overweight
Aug 4, 2026	Guggenheim	Yatin Suneja—	+129.1%	$60 → $60	Maintained	Buy
Aug 4, 2026	Wedbush	Laura Chico—	+52.7%	$38 → $40	Maintained	Outperform
Aug 4, 2026	Canaccord Genuity	Sumant Kulkarni—	+121.5%	$60 → $58	Maintained	Buy
Aug 4, 2026	Chardan Capital	Keay Nakae—	+33.6%	$35 → $35	Maintained	Buy
Jul 13, 2026	Goldman Sachs	Kevin Strang—	+68.0%	$44	Initiate	Buy
May 11, 2026	BTIG	Thomas Shrader—	+48.9%	$39 → $39	Maintained	Buy
Mar 20, 2026	Canaccord Genuity	Sumant Kulkarni—	+129.1%	$36 → $60	Maintained	Buy
Mar 19, 2026	BTIG	Thomas Shrader—	+48.9%	$39 → $39	Maintained	Buy
Mar 18, 2026	Wedbush	Laura Chico—	+45.1%	$36 → $38	Maintained	Outperform
Mar 18, 2026	Chardan Capital	Keay Nakae—	+33.6%	$35 → $35	Maintained	Buy
Mar 17, 2026	Wedbush	Laura Chico—	+45.1%	$36 → $38	Maintained	Outperform
Mar 17, 2026	Needham	Joseph Stringer—	+52.7%	$35 → $40	Maintained	Buy
Feb 24, 2026	Wolfe Research	Rudy Li—	+52.7%	$40	Initiate	Outperform
Jan 12, 2026	Wedbush	Laura Chico—	+37.5%	$32 → $36	Maintained	Outperform
Jan 5, 2026	Chardan Capital	Keay Nakae—	+33.6%	$24 → $35	Maintained	Buy
Jan 5, 2026	Canaccord Genuity	Sumant Kulkarni—	+37.5%	$28 → $36	Maintained	Buy
Dec 15, 2025	HC Wainwright & Co.	Ananda Ghosh—	+90.9%	$35 → $50	Maintained	Buy
Nov 5, 2025	Canaccord Genuity	Sumant Kulkarni—	+6.9%	$24 → $28	Maintained	Buy
Nov 5, 2025	Wedbush	Laura Chico—	+22.2%	$22 → $32	Maintained	Outperform
Nov 5, 2025	BTIG	Thomas Shrader—	+48.9%	$39 → $39	Maintained	Buy
Nov 3, 2025	JP Morgan	Jessica Fye—	-4.5%	$15 → $25	Maintained	Neutral
Oct 13, 2025	BTIG	Thomas Shrader—	+48.9%	$28 → $39	Maintained	Buy
Oct 10, 2025	Needham	Joseph Stringer—	+33.6%	$22 → $35	Maintained	Buy
Aug 13, 2025	Chardan Capital	Rudy Li—	-8.4%	$24 → $24	Maintained	Buy